Depression and Anxiety Trial, Recruiting NCT06568419 Sponsor: Solli Distriktspsykiatriske Senter Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06568419
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are currently receiving care as an outpatient at a specialised mental health service
  • People who are 18 years of age or older
  • People who are on full or partial sick leave, or receiving a work assessment allowance
  • People whose primary diagnosis falls within the ICD-10 categories F30 to F40, which covers mood disorders and anxiety-related conditions (confirm with trial site)
  • People who are currently employed

Who may not be able to join:

  • People who are currently experiencing a psychotic disorder and/or mania
  • People who are currently struggling with substance abuse, including misuse of sedative medications
  • People who are currently going through a major depressive episode
  • People who have an organic brain disease, meaning a physical condition affecting the brain
  • People who have significant difficulties with reading and writing

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pål William Wallace, PhD, Solli DPS

Phone: 0047+47018243

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Solli Distriktspsykiatriske Senter
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
1 April 2027

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Degree of Sickleave; Return to Work Self-efficacy 11

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov